This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
iot: Archive
Should You Buy PLBY Group, Inc. (PLBY) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
PLBYPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Akamai Technologies (AKAM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AKAMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can an Extended Manufacturing Footprint Benefit AST SpaceMobile?
by Supriyo Bose
ASTS expands U.S. manufacturing with new Texas and Florida sites, targeting stronger innovation and satellite output.
VSATNegative Net Change IRDMNegative Net Change ASTSNegative Net Change
communications iot mobile tech-stocks
Sinclair (SBGI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SBGIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
AT&T vs. Verizon: Which Wireless Giant is a Better Buy Now?
by Supriyo Bose
T edges ahead with stronger valuation, better stock performance and strategic spectrum gains, giving it a slight lead over VZ.
TNegative Net Change VZPositive Net Change TMUSPositive Net Change
communications iot mobile tech-stocks telecom
Profound Medical (PROF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PROFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Globus Medical (GMED) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
GMEDNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
ASTS vs. IBM: Which Connectivity Innovator is the Better Buy Today?
by Supriyo Bose
IBM's steady growth, improving estimates and lower valuation help it stand out as the stronger pick in this two-stock connectivity showdown.
TNegative Net Change MSFTNegative Net Change IBMPositive Net Change VZPositive Net Change ASTSNegative Net Change
artificial-intelligence cloud-computing communications iot mobile software tech-stocks telecom
CLS vs. PINS: Which Stock Has More Upside Potential Now?
by Supriyo Bose
Celestica's surging growth, stronger valuation and outperforming stock price make it the more compelling pick over its digital rival.
AMZNPositive Net Change CLSNegative Net Change SANMPositive Net Change PINSPositive Net Change
advertising artificial-intelligence electronics internet-content iot social-media tech-stocks
Qualys (QLYS)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
QLYSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
3 Wireless Stocks Likely to Thrive Against Industry Shortcomings
by Supriyo Bose
CCOI, ATNI and CMBM are set to ride long-term gains from 5G momentum and rising demand for wireless connectivity despite near-term headwinds.
CCOIPositive Net Change ATNINegative Net Change CMBMPositive Net Change
communications iot mobile tech-stocks
GLW vs. ANET: Which AI Infrastructure Stock Offers More Upside?
by Supriyo Bose
Corning's demand rebound, AI-driven fiber growth and cheaper valuation position it ahead of Arista in the battle for AI infrastructure upside.
GLWNegative Net Change ANETPositive Net Change
artificial-intelligence cloud-computing communications iot saas tech-stocks telecom
Qualcomm vs. Intel: Which Chip Stock is the Better Buy Now?
by Supriyo Bose
INTC edges out QCOM as valuation, price momentum and growth prospects give it a slight lead in the latest chip stock comparison.
INTCPositive Net Change QCOMPositive Net Change NVDAPositive Net Change AVGOPositive Net Change
artificial-intelligence communications computers iot semiconductor tech-stocks
Gorilla Technology Q3 Earnings Miss Estimates, Pipeline Increased
by Zacks Equity Research
GRRR's Q3 revenues jump 32% despite an earnings miss, as its project pipeline climbs past $7 billion.
SLBNegative Net Change GENPositive Net Change GRRRNegative Net Change
artificial-intelligence earnings internet iot
3 Wireless Non-US Stocks Set to Thrive Against Industry Conundrums
by Supriyo Bose
The fast-track 5G rollout and solid wireless traction should help the Zacks Wireless Non-US industry thrive despite short-term headwinds. AMX, TLSNY and TIMB are well-positioned to make the most of the demand for seamless connectivity solutions.
AMXNegative Net Change TLSNYNegative Net Change TIMBNo Net Change
communications iot mobile tech-stocks
MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
MDXGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Join the CLS Bandwagon on Rising Earnings Estimates?
by Supriyo Bose
CLS' rising earnings estimates and accelerating AI-driven demand spotlight its expanding role in high-value tech infrastructure.
JBLPositive Net Change FLEXNegative Net Change CLSNegative Net Change
artificial-intelligence electronics iot tech-stocks
Nexa Resources S.A. (NEXA)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
NEXAPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Twilio (TWLO) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TWLOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Gorilla Technology to Report Q3 Earnings: Here's What to Expect
by Zacks Equity Research
GRRR readies its Q3 reports as strong first-half gains, global demand and major contracts set the stage for results.
SLBNegative Net Change GENPositive Net Change GRRRNegative Net Change
earnings internet iot tech-stocks
Should You Avoid ASTS Stock Post Lackluster Q3 Performance?
by Supriyo Bose
AST SpaceMobile's weak Q3 results and rising costs cloud its outlook even as new satellites and carrier deals aim to bolster its long-term plans.
TNegative Net Change VZPositive Net Change AVNWPositive Net Change CMTLPositive Net Change ASTSNegative Net Change
communications iot mobile tech-stocks telecom
Can the Launch of an Advanced Quantum Processor Propel IBM Stock?
by Supriyo Bose
IBM unveils its most advanced quantum processor yet, boosting software synergy and fueling optimism for future growth despite margin pressures.
AMZNPositive Net Change MSFTNegative Net Change IBMPositive Net Change
artificial-intelligence cloud-computing computers iot saas tech-stocks
Are Declining Earnings Estimates an Indication to Avoid INTC Stock?
by Supriyo Bose
Falling earnings estimates cloud Intel's outlook, even as AI chip launches and major investments aim to revive growth.
INTCPositive Net Change AMDNegative Net Change NVDAPositive Net Change
artificial-intelligence computers iot semiconductor tech-stocks telecom
Alto Ingredients (ALTO) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ALTONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
ASTS Reports Wider-Than-Expected Q3 Loss Despite Top-Line Expansion
by Zacks Equity Research
AST SpaceMobile posts a wider-than-expected Q3 loss as inflation, tariffs and rising costs weigh on performance despite revenue growth.
JBLPositive Net Change WDAYPositive Net Change KEYSPositive Net Change ASTSNegative Net Change
communications earnings iot mobile tech-stocks